CG
CGTX
Cognition Therapeutics, Inc. - Common Stock
NASDAQMarket Cap
P/E Ratio
54.44
Dividend Yield
0.44%
Volume
52W High
52W Low
Avg Volume
Financial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
No financial data available
Institutional Ownership
What does this mean?Top institutions holding CGTX
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Oct 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Oct 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Oct 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Sep 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Oct 2025 |
ETF Holdings
What does this mean?Top ETFs holding CGTX
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 34,911,896 |
| VGT | 6.20% | 48,421,334 |
| SPY | 4.50% | 9,825,038 |
| IVV | 4.20% | 5,113,328 |
| VOO | 3.80% | 31,037,484 |
Trade
Buy/Sell via broker links (affiliate).
Trading 212
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Sign in
to save trades to your portfolio tracker.
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Sign in
to place paper orders.
Price Alerts
Notify when CGTX crosses your target.
Sign in
to create alerts and sync them across devices.
Company Info
What does this mean?About
Cognition Therapeutics, Inc. - Common Stock (CGTX) is included in the Stock Monitor database for research and watchlists.
CEO
N/A
Employees
40,644
IPO Date
Jan 1, 2000
Analyst Ratings
What does this mean?Piper Sandler
Dec 15, 2025
Buy
Goldman Sachs
Nov 23, 2025
Overweight
Morgan Stanley
Nov 6, 2025
Buy
JPMorgan
Oct 20, 2025
Buy
Bernstein
Oct 3, 2025
Buy
Price Target
$425.53